We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Modulator of Regulatory T-Cell Behavior Identified

By LabMedica International staff writers
Posted on 25 May 2015
Print article
Image: Micrograph of human intestine from a patient with an inflammatory disease (Photo courtesy of the University of Manchester).
Image: Micrograph of human intestine from a patient with an inflammatory disease (Photo courtesy of the University of Manchester).
A mechanism has been identified that explains how regulatory T-cells (Treg cells) suppress harmful T-cell responses that can lead to the development of autoimmune diseases such as type I diabetes and rheumatoid arthritis.

Treg cells play a pivotal role in suppressing self-harmful T-cell responses, but how they mediate suppression to maintain immune homeostasis and limit responses during inflammation has not been well understood.

Investigators at the University of Manchester (United Kingdom) examined the role of the integrin alphavbeta8 in the modulation of Treg behavior. They reported in the May 12, 2015, online edition of the journal Immunity that effector Treg cells expressed high amounts of integrin alphavbeta8, which enabled them to activate latent transforming growth factor-beta (TGF-beta).

Working with a mouse model, the investigators showed that specific deletion of integrin alphavbeta8 from Treg cells did not result in the generation of spontaneous inflammatory or autoimmune behavior, suggesting that this pathway was not important in Treg cell-mediated maintenance of immune homeostasis. However, Treg cells lacking expression of integrin alphavbeta8 were unable to suppress pathogenic T-cell responses during active inflammation.

Senior author Dr. Mark Travis, lecturer in inflammation research at the University of Manchester, said, “Regulatory T-cells are already being used in clinical trials where the cells are taken from the patient, multiplied, and then given back to the patient to suppress their illness. By understanding the mechanisms behind how regulatory T- cells work, we could improve on these therapies, which can be potentially useful in conditions ranging from type I diabetes to multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease. This knowledge is vitally important when trying to make regulatory T-cells for therapy. By knowing the importance of this pathway, we can now work to improve the suppressive nature of regulatory T-cells to make them more effective as treatments for disease.”

“It is fascinating that getting rid of just one molecule can have such an impact on the body’s ability to fight disease. Our research is all about how the molecules interlink and react to each other, and in certain situations targeting just one molecule can boost or inhibit a response, said Dr. Travis.”

Related Links:

University of Manchester


Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Auto-Chemistry Analyzer
CS-1200
New
Toxoplasma Gondii Test
Toxo IgG ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.